Skip to Main Content

Author Details

Joshua C Anderson
University of Alabama at Birmingham
2005
45
18
Jake Y. Chen (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37328102Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival.Am J Pathol2023
37681903Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.Cells2023
37328102Inhibition of Erb-B2 Receptor Tyrosine Kinase 3 and Associated Regulatory Pathways Potently Impairs Malignant Peripheral Nerve Sheath Tumor Proliferation and Survival.Am J Pathol2023
37681903Tumor Treating Fields Alter the Kinomic Landscape in Glioblastoma Revealing Therapeutic Vulnerabilities.Cells2023
35272839Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).J Pediatr Surg2022
36008408Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.Nat Commun2022
36052698Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.Circ Res2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
35272839Serine-Threonine Kinase Receptor Associate Protein (STRAP) confers an aggressive phenotype in neuroblastoma via regulation of Focal Adhesion Kinase (FAK).J Pediatr Surg2022
35179826Cardiomyocyte stromal interaction molecule 1 is a key regulator of Ca<sup>2+</sup> -dependent kinase and phosphatase activity in the mouse heart.Physiol Rep2022
35852875An in vivo model of glioblastoma radiation resistance identifies long noncoding RNAs and targetable kinases.JCI Insight2022
36052698Fibroblast GSK-3α Promotes Fibrosis via RAF-MEK-ERK Pathway in the Injured Heart.Circ Res2022
36008408Selective suppression of melanoma lacking IFN-γ pathway by JAK inhibition depends on T cells and host TNF signaling.Nat Commun2022
35179826Cardiomyocyte stromal interaction molecule 1 is a key regulator of Ca<sup>2+</sup> -dependent kinase and phosphatase activity in the mouse heart.Physiol Rep2022
34206917Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.Cancers (Basel)2021
33727604PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.Sci Rep2021
34206917Serine-Threonine Kinase Receptor-Associated Protein (STRAP) Knockout Decreases the Malignant Phenotype in Neuroblastoma Cell Lines.Cancers (Basel)2021
33558335miR-31 Displays Subtype Specificity in Lung Cancer.Cancer Res2021
33727604PIM kinases mediate resistance to cisplatin chemotherapy in hepatoblastoma.Sci Rep2021
33558335miR-31 Displays Subtype Specificity in Lung Cancer.Cancer Res2021
32231273Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.Oncogene2020
32231273Therapeutically actionable PAK4 is amplified, overexpressed, and involved in bladder cancer progression.Oncogene2020
32523959Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.Kidney Dis (Basel)2020
33133138Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth.Front Genet2020
33077834A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.Oncogene2020
33133138Combining PARP and DNA-PK Inhibitors With Irradiation Inhibits HPV-Negative Head and Neck Cancer Squamous Carcinoma Growth.Front Genet2020
33077834A cell-penetrating MARCKS mimetic selectively triggers cytolytic death in glioblastoma.Oncogene2020
32523959Leukemia Inhibitory Factor Signaling Enhances Production of Galactose-Deficient IgA1 in IgA Nephropathy.Kidney Dis (Basel)2020
30942445Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol2019
31628288Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.J Neurosurg2019
31565187The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.Oncotarget2019
30733195Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer.Cancer Res2019
30942445Myristoylated alanine-rich C-kinase substrate effector domain phosphorylation regulates the growth and radiation sensitization of glioblastoma.Int J Oncol2019
31311651Differential escape mechanisms in cetuximab-resistant head and neck cancer cells.Biochem Biophys Res Commun2019
31628288Intratumoral spatial heterogeneity of BTK kinomic activity dictates distinct therapeutic response within a single glioblastoma tumor.J Neurosurg2019
31311651Differential escape mechanisms in cetuximab-resistant head and neck cancer cells.Biochem Biophys Res Commun2019
31565187The effects of focal adhesion kinase and platelet-derived growth factor receptor beta inhibition in a patient-derived xenograft model of primary and metastatic Wilms tumor.Oncotarget2019
30733195Spleen Tyrosine Kinase-Mediated Autophagy Is Required for Epithelial-Mesenchymal Plasticity and Metastasis in Breast Cancer.Cancer Res2019
29402301Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.J Ovarian Res2018
29946469Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose.Biomark Res2018
30130366Kinomics toolbox-A web platform for analysis and viewing of kinomic peptide array data.PLoS One2018
29402301Sialylation of EGFR by the ST6Gal-I sialyltransferase promotes EGFR activation and resistance to gefitinib-mediated cell death.J Ovarian Res2018
29849102Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.Sci Rep2018
29946469Kinomic profiling of glioblastoma cells reveals PLCG1 as a target in restricted glucose.Biomark Res2018
30130366Kinomics toolbox-A web platform for analysis and viewing of kinomic peptide array data.PLoS One2018
29849102Combinatorial Drug Testing in 3D Microtumors Derived from GBM Patient-Derived Xenografts Reveals Cytotoxic Synergy in Pharmacokinomics-informed Pathway Interactions.Sci Rep2018
29270528Inhibition of STAT3 Signaling Reduces IgA1 Autoantigen Production in IgA Nephropathy.Kidney Int Rep2017
28423512Kinase analysis of penile squamous cell carcinoma on multiple platforms to identify potential therapeutic targets.Oncotarget2017
28454237MARCKS phosphorylation is modulated by a peptide mimetic of MARCKS effector domain leading to increased radiation sensitivity in lung cancer cell lines.Oncol Lett2017
28418903Kinomic profiling identifies focal adhesion kinase 1 as a therapeutic target in advanced clear cell renal cell carcinoma.Oncotarget2017
  • 1 - 50 of 90

Recommended Authors

Jason K Sa
Korea University, College of Medicine
Career Start Year 2015
Number of shared co-authors 0
Johannes C van der Mijn
New York Presbyterian Hospital
Career Start Year 2012
Number of shared co-authors 0
Aleksandra M Michalowski
Center for Cancer Research, National Cancer Institute
Career Start Year 2010
Number of shared co-authors 0
Maxim Sidorov
California Pacific Medical Center Research Institute
Career Start Year 2009
Number of shared co-authors 0
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 0
Mariaelena Pierobon
Center for Applied Proteomics and Molecular Medicine, George Mason University
Career Start Year 2004
Number of shared co-authors 0
Jalna Meens
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 0
Xiaohu Zhang
National Center for Advancing Translational Sciences
Career Start Year 2003
Number of shared co-authors 0
Lixia Diao
The University of Texas MD Anderson Cancer Center
Career Start Year 2003
Number of shared co-authors 1
Bo Hu
Northwestern University Feinberg School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Elena Ivanova
Dana-Farber Cancer Institute
Career Start Year 2003
Number of shared co-authors 0
Aik Choon Tan
Huntsman Cancer Institute, The University of Utah
Career Start Year 2003
Number of shared co-authors 3
Trever G Bivona
University of California san francisco
Career Start Year 2002
Number of shared co-authors 1
Annette T Byrne
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 0
Jun Yao
The University of Texas MD Anderson Cancer Center
Career Start Year 1997
Number of shared co-authors 1
Shi-Yuan Cheng
Northwestern University Feinberg School of Medicine
Career Start Year 1996
Number of shared co-authors 1
John D Gordan
Quantitative Biosciences Institute (QBI), University of California San Francisco
Career Start Year 1996
Number of shared co-authors 0
Kan V Lu
Clinical Medical Research Center of Hepatic Surgery at Hubei Province
Career Start Year 1995
Number of shared co-authors 0
Krister Wennerberg
University of Copenhagen
Career Start Year 1994
Number of shared co-authors 1
Paul S Mischel
Stanford University
Career Start Year 1994
Number of shared co-authors 0
Livio Trusolino
Candiolo Cancer Institute - FPO IRCCS
Career Start Year 1993
Number of shared co-authors 0
Frank B Furnari
University of California San Diego
Career Start Year 1992
Number of shared co-authors 1
Donald M O'Rourke
Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania
Career Start Year 1991
Number of shared co-authors 0
Terrance G Johns
Telethon Kids Institute
Career Start Year 1990
Number of shared co-authors 0
Emile E Voest
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 0
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 0
Wei Zhang
The University of Texas MD Anderson Cancer Center
Career Start Year 1988
Number of shared co-authors 1
William A Weiss
University of California san francisco
Career Start Year 1985
Number of shared co-authors 2
Gordon B Mills
Knight Cancer Institute, Oregon Health and Sciences University
Career Start Year 1976
Number of shared co-authors 5
Antonio Jimeno
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Christopher D Willey
University of Alabama at Birmingham
Co-authored papers 38
Eddy S Yang
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Co-authored papers 12
George Yancey Gillespie
Heersink School of Medicine, The University of Alabama at Birmingham
Co-authored papers 8
Nicholas Eustace
City of Hope National Medical Center
Co-authored papers 6
Anita B Hjelmeland
University of Alabama at Birmingham
Co-authored papers 5
Catherine P Langford
University of Alabama at Birmingham
Co-authored papers 4
David K Crossman
University of Alabama at Birmingham
Co-authored papers 3
William E Grizzle
University of Alabama at Birmingham
Co-authored papers 3
Dongquan Chen
University of Alabama at Birmingham
Co-authored papers 3
Krzysztof Kiryluk
Columbia University
Co-authored papers 2
Chuan Xing
The University of Alabama at Birmingham, Hazelrig Salter Radiation Oncology Center
Co-authored papers 2
Jonas S Almeida
National Cancer Institute (NCI)
Co-authored papers 2
Ali G Gharavi
Columbia University College of Physicians and Surgeons
Co-authored papers 2
Kevin J Lee
Mayo Clinic
Co-authored papers 1
Christian T Stackhouse
Co-authored papers 1
Paul A Goepfert
Co-authored papers 1
Zongliang Yue
University of Alabama at Birmingham, USA Informatics Institute
Co-authored papers 1
Toni K Choueiri
Dana-Farber Cancer Institute
Co-authored papers 1
Jake Y Chen
Co-authored papers 1
Christopher Ryan Miller
University of Illinois at Urbana-Champaign
Co-authored papers 1
Jessy S Deshane
Co-authored papers 1
Thanh Nguyen
University of Alabama at Birmingham
Co-authored papers 1
Michael S Saag
University of Alabama at Birmingham
Co-authored papers 1
James R Rowland
The Ohio State University
Co-authored papers 1
Jake Y. Chen (CM4AI)
University of Alabama at Birmingham
Co-authored papers 1
Jelai Wang
University of Alabama at Birmingham
Co-authored papers 1
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Co-authored papers 1
Zechen Chong
Heersink School of Medicine, University of Alabama at Birmingham
Co-authored papers 1
Nallasivam Palanisamy
Vattikuti Urology Institute
Co-authored papers 1
Camille Ragin
Fox Chase Cancer Center
Co-authored papers 1
Release 1.2